Saving Money On Volume: Obama Advisor Talks Cost-Containment At ASCO
ORLANDO, Fla. - Cost-containment in oncology will have to focus on volume rather than price, according to Obama administration health advisor Ezekiel Emanuel
You may also be interested in...
Deal Snapshot: The firms are partnering on a digital therapeutic for schizophrenia in a deal potentially worth $500m.
“The spin-off will establish two separate companies, a fully integrated, pure play, eye health company built on the iconic Bausch Health brand and a long history of innovation, and an international diversified pharmaceutical company with leading physicians in gastroenterology, dermatology, aesthetics, neurology and an international pharma business,” says CEO Joseph Papa.
The company formerly known as Valeant, put together by a series of mergers, is ready to spin out the legacy Bausch + Lomb eyecare business that it used in its rebranding.